Nasus Pharma Ltd. Net Asset Quality Index
Nasus Pharma Ltd. net asset quality index. Nasus Pharma Ltd. (NSRX) has a Net Asset Quality Index of 55.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $5.00 Million minus total liabilities of $2.24 Million yields net assets of $2.77 Million. A higher index indicates a stronger, lower-leverage balance sheet. See NSRX net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Nasus Pharma Ltd. (2022–2025)
Net asset quality index of Nasus Pharma Ltd. from 2022 to 2025. This chart shows how Nasus Pharma Ltd.'s Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the index stands at 55.3%, representing net assets of $2.77 Million against total assets of $5.00 Million USD. Check Nasus Pharma Ltd. tangible equity quality to evaluate the tangible quality of the company's equity base.
Nasus Pharma Ltd. Net Asset Quality Index by Year (2022–2025)
Nasus Pharma Ltd. net asset quality index by year from 2022 to 2025. The table below presents the year-by-year Net Asset Quality Index for Nasus Pharma Ltd. from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Nasus Pharma Ltd. (NSRX) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 55.3% | $2.77 Million | $5.00 Million | $2.24 Million | ▲ +503.3 pp |
| 2024 | -448.0% | $-3.21 Million | $717.00K | $3.93 Million | ▲ +407.2 pp |
| 2023 | -855.2% | $-3.80 Million | $444.00K | $4.24 Million | ▼ -187.3 pp |
| 2022 | -667.9% | $-2.79 Million | $417.00K | $3.20 Million | — |